Health
Selecting SARS-CoV-2 inhibitors in human airway epithelial cells – News-Medical.Net
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe…
In a recent article currently available on the bioRxiv* preprint server, researchers from Belgium and the U.S. demonstrated a robust replication model for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates in primary human epithelial cells at the air-liquid interface and appraised the antiviral effect of selected viral replication inhibitors.
The vaccination campaign is our current answer against the ongoing spread of SARS-CoV-2 and coronavirus disease (COVID-19) pandemic….
-
Noosa News24 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General24 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Business17 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News22 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days